Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Svälta eller göda inför planerad kirurgi?
Mikael Wirén [email protected]
Agenda
• Nutri>onsbedömning • Preopera>v viktnedgång • Preopera>vt nutri>onsstöd • Pre-‐op kolhydratuppladdning • Preopera>v lågkaloridiet
17-‐05-‐11 Kirub 17 2
Varför?
H.O Studley, JAMA 1936, 106, 458
28 cases – 1 death 3.5%
18 cases – 6 deaths 33.3%
20%
17-05-11 3 Kirub 17
Impact of malnutri>on on gastrointes>nal surgical pa>ents. Mosquera C et al. J Surg Res 2016;95-‐101
• N=490, mean age 64 y, 50,6 % females • Major elec>ve GI-‐surgery • 19% moderately or severely malnourished • Malnutri>on worsens length of stay (OR=1,67) • Malnutri>on worsens costs (OR=2,49) • No significant differences in complica>ons, mortality or readmission rates.
17-‐05-‐11 Kirub 17 4
Generella problem vid GI-‐kirurgi
Infection - MOF
Anxiety Pain
Nausea
Vomiting
Fluid balance disturbancies Lack of healing
Anastomotic leakage
Tissue contamination
Malnutrition
Cardio-respiratory complications
17-05-11 5 Kirub 17
När?
Trauma Trauma
Trauma Respons
17-05-11 6 Kirub 17
VÄRLDENS FÖRSTA PUBLICERADE RANDOMISERADE STUDIE
Studiedesign • 1747 ankom Salisbury med 12 sjömän med symptom på
skörbjugg. Alla bodde under samma förhållanden och fick samma kost.
• Men dessutom erhöll de något av de sex olika kosbllskoc
som Lind ville undersöka; cider, vitriolelixir, vinäger, havsvacen, havrevacen eller cirtusfrukter.
• Det visade sig övertygande ac behandlingen med
citrusfrukter var bäst -‐ de pa>enterna var helt arbetsföra efer 6 dagar. Näst bäst var cider -‐ de männen var på bäcringsvägen då försöket avbröts efer gorton dagar. Alla de övriga >llskocen var helt utan effekt.
• Metabolism • Protein catabolism • Immunological function • Scavenger functions
Malnutrition Disease Trauma Tumour
Surgery Drugs
Antibiotics Nutrition
Growth factors
Mortality Morbidity
Body composition Serum proteins
Immun parameters Molecular biology
17-05-11 9 Kirub 17
Sjukdomsrelaterad malnutri>on
• Kronisk inflamma>on • Infek>on • Malignitet • Efer trauma – Kirurgisk behandling
• Läkemedelseffekter • Psykiatrisk sjukdom
Nutri>on and abdominal surgery
• Obstruc>ng upper GI diseases – Malignancies – Func>onal diseases
• Dysfunc>on of the lower GI tract – Inflammatory bowel disease – Short bowel
• Malnutri>on + major surgery
17-05-11 11
Malignant obstruc>on
• Esofageal cancer • Gastric cancer • Duodenal/pancrea>c-‐cancer
17-05-11 12
Malignancy and malnutri>on
• Pankrea>c cancer • Liver cancer • Peritoneal carcinomatosis
17-05-11 13
Benign obstruc>ons
• Esofagus – Diver>culum – Esofagi>s – Stricture
• Stomach – Stenosis afer ulcer – Stenosis afer surgery (BI, BII, Roux-‐Y)
• Duodenum – Malrota>on (Ladd´s band)
17-05-11 14
Dysfunc>on of upper GI-‐tract
• Esofagus – Achalasia – Mo>lity disorders
• Stomach – Gastric paresis (DM)
• Small intes>ne – Pseudoobstruc>on
17-05-11 15
TREATMENT Parenteral and enteral op>ons
17-05-11 16
17
Nya koncept
• Tidig enteral nutri>on • Immunonutri>on • Tillväxpaktorer och specifika nutrienter – Glutamin
• Pre-‐opera>v kolhydratuppladdning • Blodsockerkontroll • Natrium och vätskerestrik>on
17-‐05-‐11 Kirub 17
How much to give?
� Fluid 30 ml/kg � Adequate urinary output
� Energy � 25-‐30 kcal/kg
� Protein � 0,15-‐0,3 g N/kg = 1-‐2 g protein/kg (1 g N= 6,25 g protein=25 g muskel)
� Sodium and Potassium � Basal requirements + losses
� Indirect calorimetry
17-05-11 18
When to use parenteral nutri>on?
• When the GI-‐tract cannot be used – High output intes>nal fistulas – Severe pancrea>>s – Short bowel – Pseudoobstruc>on
• In addi>on to enteral nutri>on
17-05-11 19
Agenda -‐preopera>v nutri>on
• Varför? • Vid vilken typ av kirurgi? – Övre eller kolorektal?
• När? – Vad har högst prioritet?
• Hur? – Oralt, enteralt, parenteralt?
• Evidens? 17-‐05-‐11 Kirub 17 20
17-‐05-‐11 Kirub 17 21
Albumin
• Albumin is a single polypep>de responsible for five main func>ons:
• (1) maintenance of colloid osmo>c pressure; • (2) binding and transport of solutes; • (3) free radical scavenging; • (4) platelet func>on inhibi>on and an>thrombo>c effect;
• (5) beneficial effects on vascular permeability in the sebng of shock and sepsis[1].
17-‐05-‐11 Kirub 17 22
Truong A et al.
World J Gastrointest Surg 2016 May 27; 8(5): 353-‐362
• Although albumin remains a flawed marker of nutri>on, it offers clear prognos>c value in predic>ng pa>ent outcomes afer colorectal surgery.
• Hypoalbuminemia significantly influences the length of hospital stay and complica>on rates, specifically surgical site infec>on, enterocutaneous fistula, and DVT forma>on.
• Although clinical hypoalbuminemia is classically defined as serum concentra>ons < 3.0 g/dL, clinical judgment must account for albumin levels ≤ 3.4 g/dL as even modest hypoalbuminemia can affect outcomes.
• Surgical delay for preopera>ve nutri>on has been shown to improve the morbidity and mortality in pa>ents with severe nutri>onal risk.
• Hypoalbuminemic pa>ents may benefit from a staged colorectal resec>on vs a single opera>on, especially in the sebng of IBD.
17-‐05-‐11 Kirub 17 23
HÖGRISKPATIENTER INOM ÖVRE GI
17-‐05-‐11 Kirub 17 24
Pre-‐op evalua>on in high risk pa>ents
• Inhospital mortality in Europe = 3-‐4% • Morbidity increases with BMI but not mortality in the ICU
• Satura>on < 92! • Male, BMI>50, age>50, CV disease… • Opioid free anaesthesia
17-‐05-‐11 Kirub 17 25
17-‐05-‐11 Kirub 17 26
CMAJ. 2011 October 4; 183(14): e1059–e1066. Using the Edmonton obesity staging system to predict mortality in a populaDon-‐representaDve cohort of people with overweight and obesity Raj S. Padwal, MSc MD, Nicholas M. Pajewski, PhD, David B. Allison, PhD, and Arya M. Sharma, MD PhD
17-‐05-‐11 Kirub 17 27
VILKEN BETYDELSE HAR KIRURGISK TEKNIK?
17-‐05-‐11 Kirub 17 28
Surgical Skill and ComplicaDon Rates aPer Bariatric Surgery John D. Birkmeyer, M.D et al. for the Michigan Bariatric Surgery Collabora>ve
N Engl J Med 2013; 369:1434-‐1442
• Mean summary ra>ngs of technical skill ranged from 2.6 to 4.8 across the 20 surgeons.
• The bocom quar>le of surgical skill, as compared with the top quar>le, was associated with higher complica>on rates (14.5% vs. 5.2%, P<0.001) and higher mortality (0.26% vs. 0.05%, P=0.01).
• The lowest quar>le of skill was also associated with longer opera>ons (137 minutes vs. 98 minutes, P<0.001) and higher rates of reopera>on (3.4% vs. 1.6%, P=0.01) and readmission (6.3% vs. 2.7%) (P<0.001).
17-‐05-‐11 Kirub 17 29
Who is important? “The most important person in the opera>ng room is the pa>ent.” — Russell John Howard (1875–1942) “The most important result of any surgical opera>on is a live pa>ent.” — Charles H. Mayo (1865–1939) “It is becer if the pa>ent goes to the plas>c surgeon afer an opera>on, with a large scar, than to the pathologist with a small one.” — Denis M. Arkhipov
17-‐05-‐11 Kirub 17 30
KAN MAN SVÄLTA PATIENTER FÖRE OPERATION?
17-‐05-‐11 Kirub 17 31
17-‐05-‐11 Kirub 17 32
17-‐05-‐11 Kirub 17 33
Arch Surg. 2011 Nov;146(11):1300-‐5
17-‐05-‐11 Kirub 17 34
Arch Surg. 2011 Nov;146(11):1300-‐5
17-‐05-‐11 Kirub 17 35
Arch Surg. 2011 Nov;146(11):1300-‐5
LÖNAR SIG PREOPERATIV KOLHYDRATUPPLADDNING?
17-‐05-‐11 Kirub 17 36
17-‐05-‐11 Kirub 17 37
17-‐05-‐11 Kirub 17 38
17-‐05-‐11 Kirub 17 39
GASTROINTESTINALKANALENS ANATOMI, EMBRYOLOGI OCH FYSIOLOGI
Vi börjar med det basala…
17-‐05-‐11 Kirub 17 40
17-‐05-‐11 Kirub 17 41
Nutri>on, intes>nal barrier and liver func>on
17-‐05-‐11 Kirub 17
GALT Kupfer cell dysfunction
Liver Steatosis
Cholestasis
Intestine Permeability
sIgA BTL
Enteral nutrition not possible
Total parenteral nutrition
42
Fallbeskrivningar
Korcarmsyndrom Sviktande tarm
Female born 1962
• 2010 Gastric bypass • Aug 2012 Internal hernia>on, intes>nal ischemia
17-‐05-‐11 Kirub 17 44
Female born 1962
• 2010 Gastric bypass • Aug 2012 Internal hernia>on, intes>nal ischemia
• Arrival Open abdomen, ven>lator and dialysis
• September Small bowel resec>on 150 cm • September Anastomo>c leakage, diversion of alimentary and biliopancrea>c limb
• October Going home afer 6 weeks 17-‐05-‐11 Kirub 17 45
Treatment op>ons?
• 55 kg, 168 cm • Albumin 15 • Normal liver func>on • Normal renal func>on • Leucocyte count and CRP normal
17-‐05-‐11 Kirub 17 46
Treatment at home
• TPN Olive oil based, 31 kcal/kg • Addex NaCl 20ml, • PPI • LMWH • Durogesic • An>fungal therapy
17-‐05-‐11 Kirub 17 47
Male born 1964
• 1996 renal transplant (Chronic glomerulonephri>s)
• 2005 GI bleeding • Burkics lymfoma (small bowel) • Chemotherapy • Small bowel perfora>on, resec>on and proximal jejunostomy
17-‐05-‐11 Kirub 17 48
What to do?
• Ongoing chemotherapy • Recurrent neutropenia • Severe sep>c episodes • High output fistula • Progressive liver dysfunc>on due to TPN?
17-‐05-‐11 Kirub 17 49
50
Paradigmskife
ü Preopera>v fasta ü Sond, dränage ü Tarmvila postopera>vt ü Tarmrengöring ü Smärtlindring vid behov ü Klara vätskor ”enl. lista” ü Svängande blsr är
naturligt post-‐op
Ø Fri dryck, uppladdning Ø Minimera sond/drän Ø Använd tarmen >digt Ø Probio>ka Ø Planerad analgesi Ø Undvik övervätskning Ø Normalisera blsr Ø Kombinera PN/EN
17-‐05-‐11 Kirub 17
Take home
• Ingen pa>ent ska försämras under pågående utredning inför kura>v behandling
• En veckas nutri>onsstöd kan förbäcra funk>on men inte kroppskomposi>on
• Preop kolhydratuppladdning kan vara av värde vid stor GI-‐kirurgi
• Friska obesa minskar levervolymen med LCD. • Sjuka obesa pa>enter ska nutrieras fullt ut.
17-‐05-‐11 Kirub 17 51
BRA NUTRITION RÄDDAR INTE DÅLIG KIRURGI MEN BRA KIRURGI KAN MISSLYCKAS OM LÄKNINGEN KOMPROMETTERAS
17-‐05-‐11 Kirub 17 52